Find valuable ACTEMRA® (tocilizumab) information, including an ACTEMRA® dosing calculator, RA patient brochure, ACTEMRA® prescription guide and the. Tocilizumab (Actemra) is a biologic reference guide with prescribing information, dosage, medication administration, and possible side effects. Each vial contains 80 mg of tocilizumab* in 4 ml (20 mg/ml). . Dose interruptions of tocilizumab for the following laboratory abnormalities are recommended in.
|Published (Last):||23 January 2009|
|PDF File Size:||4.88 Mb|
|ePub File Size:||18.97 Mb|
|Price:||Free* [*Free Regsitration Required]|
Pre-Infusion Sctemra Confirm the following: Your cholesterol levels should be checked 4 to 8 weeks after the start of your treatment, and then every 6 months after that. Your doctor also has to fill out a form called the SMN.
No information is available on presence of tocilizumab in human milk, actemra prescribing information effects of drug on breastfed infant, or effects of drug on milk production. All Interactions Sort By: Use infoormation caution if benefits outweigh risks. Has an upcoming surgery. The rate of serious infections was 9. Your email has been sent!
You may also report side effects to Genentech at Tell your healthcare provider right away if you see any signs of these symptoms:. Sweating or chills Shortness of breath Warm, actemra prescribing information or painful skin or sores on your body Feel very tired Muscle aches Blood in phlegm Diarrhea or stomach pain Cough Weight loss Burning when you urinate or urinating more often than normal Any of the following conditions that may give actemra prescribing information a higher chance of getting infections.
You may also have changes in other laboratory tests, such as your blood cholesterol levels. Rotate SC injection sites ie, thighs, abdomen, outer area of upper arm [caregiver only] and inject full amount of actemra prescribing information syringe 0. Patients must tell their doctor if they are planning to become pregnant, are pregnant, plan to breast-feed, or are breast-feeding.
This can make you more likely to get infections or make any current infection worse. No dosage adjustment required Moderate-to-severe: These injection-site reactions were mild to moderate in severity. The purpose of this registry is to check the health of the pregnant mother and her baby. You may also call Genentech at If you had hives, a rash, or experienced flushing after injecting, you should tell your healthcare provider or nurse actemra prescribing information your next injection.
European Medicines Agency – System/website unavailable
Click “OK” if you are a healthcare professional. Medication Guides Medication Guide: Biosimilar Infliximab Inflectra Hotline: Demyelinating Disorders—use with caution in patients with preexisting or recent onset demyelinating disorders. Tocilizumab should not be given to patients who have experienced anaphylaxis or other severe hypersensitivity and not re-challenged.
Genentech does not recommend and actemra prescribing information not endorse actemra prescribing information content on any third-party websites.
Giant Cell Arteritis Indicated for treatment of giant cell arteritis GCA actemra prescribing information SC once weekly in combination with a tapering course of glucocorticoids Based on clinical considerations, may consider administering mg SC every other week in combination with a tapering course of glucocorticoids May be used alone following discontinuation of glucocorticoids eg, interruption of dosing may be needed for management of dose-related laboratory abnormalities, IV administration is not approved for GCA.
IV dosing Tocilizumab is given as a 60 minute single intravenous drip infusion. Fully diluted tocilizumab solutions are compatible with polypropylene, polyethylene and polyvinyl chloride infusion bags and polypropylene, polyethylene and glass infusion bottles. Some people have died from these infections.
Reporting side effects Tell your healthcare provider right away if you are experiencing any side effects. Adults with giant cell arteritis GCA. These informaation include the Ohio and Mississippi River Valleys and the Southwest Hepatitis B or have had hepatitis B Be sure to contact your healthcare provider or nurse if you see any signs of these side effects.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Adults with moderately actemra prescribing information severely active ibformation arthritis, or RA.
Notify the supervising provider of the reaction. Forms and Documents Here you can download the form you need to enroll in Genentech Rheumatology Access Solutions and actemra prescribing information important information.
Please select a treatment to continue
The limited available data with ACTEMRA in pregnant women are not sufficient to determine whether actemra prescribing information is a drug-associated risk for major birth defects and miscarriage.
By clicking send, you acknowledge that you have permission to email the recipient with this information.
Call Genentech at Tell your healthcare provider right actemra prescribing information if you are experiencing any side effects. Do not use in pregnancy. Medication Informztion and Monitoring Intravenous Allow the fully diluted tocilizumab solution to reach room temperature prior to infusion. Print without Office Info. The fully diluted tocilizumab solutions for infusions should be stored at 36 — actemra prescribing information degrees Fahrenheit or at room temperature for up to 24 hours.
Active Hepatic disease and Hepatic impairment—use is not recommended Live vaccines — avoid use with prescribiing. Tell your healthcare provider if actemra prescribing information have these or any other side effect that bothers you or does not go away:.
Infections The rate of infections was